Pronota and Molecuence announce collaboration in protein biomarker discovery
Pronota NV announced that it has entered into an agreement with Molecuence Corporation, a wholly owned subsidiary of Mitsubishi Chemical Corporation, to discover and validate protein biomarkers in stroke. Pronota will apply its proprietary platforms for protein biomarker discovery (MASStermind®) and biomarker verification (MASSterclass™) to this project. The financial terms have not been disclosed.
“We’re finding potential collaborators are increasingly persuaded by our track record of not only being able to identify novel protein biomarkers, but also of taking these successfully through the verification process to show they are true, robust and clinically relevant discoveries. We’re delighted to be working with Molecuence, who are one of the leaders in the field of protein biomarker development for diagnostic applications”, commented Nick McCooke, CEO of Pronota.
Most read news
Other news from the department business & finance
Get the analytics and lab tech industry in your inbox
By submitting this form you agree that LUMITOS AG will send you the newsletter(s) selected above by email. Your data will not be passed on to third parties. Your data will be stored and processed in accordance with our data protection regulations. LUMITOS may contact you by email for the purpose of advertising or market and opinion surveys. You can revoke your consent at any time without giving reasons to LUMITOS AG, Ernst-Augustin-Str. 2, 12489 Berlin, Germany or by e-mail at revoke@lumitos.com with effect for the future. In addition, each email contains a link to unsubscribe from the corresponding newsletter.
Most read news
More news from our other portals
Last viewed contents
Oxford Instruments strengthens links with Taiwan through mutual co-operation and understanding
UMC Utrecht and VectorY Therapeutics collaborate in ALS Biomarker Study - Finding these biomarkers is expected to help diagnose ALS and monitor disease progression and improve the design of future clinical studie
SemBioSys Genetics and Syngenta Enter Into Agreement on Protein and Antibody Purification Technology - Deal between biotech companies will strengthen capabilities in biopharmaceuticals
'Twist and shine': Development of a new photoluminescent sensor material
Scientists can track origin of shark fins using 'zip codes' in their DNA - Studies show that coastal sharks have 'DNA zip codes' that can reveal where they were born; underscores potential of DNA testing to monitor fin trade